New Coverage

Bearish Valeant Pharmaceuticals Intl Inc (VRX) Analyst Sent Shares Tumbling

Goldman Sachs’ Dana Flanders sheds new insights on Valeant from a bearish standpoint, spotting 5% in loss potential for the stock.

Twitter Inc (TWTR) Gains a New Bull Who Advises to “Get in Early” on the Stock

Summit Redstone’s Jonathan Kees thinks the market is underestimating Twitter’s turnaround.

This Analyst Finds It Best to Wait on Buying Square Inc (SQ) Until More Attractive Entry Point Comes Around

Cowen’s Georgios Mihalos makes a neutral case on Square’s opportunity, giving kudos to its “Build with Square” integrated strategy, but seeing growth opportunities priced into the current stock price.

Meet Apple Inc.’s (AAPL) New Skeptic

Wells Fargo’s Aaron Rakers sees 14% upside potential for AAPL stock, but spotlights volatility down the line.

Helios and Matheson Analytics Inc’s (HMNY) Many Monetization Ways Have Attracted a New Bull

Maxim is confident that HMNY’s recent 52% purchase of MoviePass will usher in commercial leverage.

Dynavax Technologies Corporation (DVAX) Gains a Cantor Bull on Back of Compelling HBV Opportunity

Analyst initiates a bullish perspective on Dynavax, ascribing a probability of 95% approval for its lead asset.